Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “MASTITIS”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 325 records · Page 18Linked to original sources

Antibiotic susceptibility profiles for mastitis treatment.

Susceptibility tests were performed on milk samples representing prevalent mastitis infections in certain herds. Susceptibility patterns of the same bacterial species from several mastitis infections in the same herd were consistent. The herd antibiotic susceptibility profiles were used as a basis for selecting antibiotics for treatment of all such mastitis cases in that herd. A high degree of correlation was seen between the susceptibility test results and treatment results. Susceptibility patterns of the same bacterial species from mastitis infections in different herds varied greatly, which indicated that any one antibiotic would not work equally well against the same bacterial infection in every herd. Therefore, treatment should be selected on the basis of susceptibility test results. When both Streptococcus and Staphylococcus mastitis occurred in the same herd, the susceptibility patterns for the 2 bacterial species varied widely. Therefore, for herds that experienced both streptococcal and staphylococcal mastitis, antibiotics to which both bacterial species were susceptible were used for treatment.

Ampicillin↗

Haemophilus somnus: investigations of its potential role in bovine mastitis.

Mammary glands of 6 lactating Holstein cows were inoculated with Haemophilus somnus strain 43826. Three cows developed chronic mastitis and shed bacteria for up to 1 year. Three cows developed acute gangrenous mastitis, with evidence of bacteremia and endotoxemia. Cows with gangrenous mastitis had lower somatic cell counts early after inoculation in affected quarter secretions compared with those in cows that developed chronic mastitis. Cows with gangrenous mastitis developed hypocalcemia, hypoalbuminemia, azotemia, hyperbilirubinemia, mildly increased serum aspartate aminotransferase and creatine kinase activity, and a marked neutropenia with a degenerative left shift. Histopathologic examination of gangrenous quarters revealed edema, necrosis, and vascular thrombosis with few inflammatory cells. A limited survey failed to recover H somnus from dairy cows with clinical mastitis or from mammary secretions from 41 beef cattle at an abattoir.

Animals↗

[Summer mastitis: pathogenesis, losses, incidence and prevention].

In cases of summer mastitis, several other bacteria, particularly anaerobes, are isolated in addition to C. pyogenes. The fly Hydrotaea irritants which also causes 'broken heads' in sheep and is therefore referred to as the 'sheep head fly', is universally regarded as the most important vector of summer mastitis. The annual losses caused by summer mastitis are substantial. The incidence of summer mastitis varies annually and monthly. Summer mastitis is particularly observed on sandy soil, less often on peat and hardly ever on clay. This is in accordance with the habitats of Hydrotaea irritans. Several measures to prevent summer mastitis are available to farmers. When fly repellents or agents protecting the teat openings are used, fair results are obtained. Synthetic pyrethroids would appear to offer better prospects, however, because of their long-acting character. Results obtained using C. pyogenes vaccines are disappointing. Long-acting antibiotics offer good prospects in yearlings in the 1-2 year range. Findings reported in the literature show that treatment of dry cows during the dry period, repeated twice at an interval of from three to four weeks, offers the most promising prospects. In view of the small teat openings of calves, fly repellents or agents protecting the teat openings will be most successful.

Animals↗

[Etiological study of mastitis in cows].

The rapid mastitis test was employed to study a total of 13 880 cows on 40 farms. Positive for mastitis proved 2384 udder quarters. Clinically manifested mastitis was established in 3.23 per cent of the cases, subclinical mastitis - in 58.14 per cent, carrier status - in 12.55 per cent, secretion disturbances - in 22.58 per cent, and normal proved 3.84 per cent. In the mastitis-positive cases pathogenic streptococci were isolated in 57.14 per cent of the quarters, staphylococci - in 20.77 per cent, Corynebacteria - in 9.09 per cent, and other bacteria - in 5.19 per cent. In the cases with subclinical mastitis staphylococci accounted for 40.93 per cent, streptococci - for 38.7 per cent, Corynebacteria - for 14.22 per cent, and other organisms - for 6.0 per cent. Most frequently encountered were the carriers of staphylococci - 46.8 per cent, followed by those of Corynebacteria - 26.4 per cent, and of streptococci - 20.73 per cent.

Animals↗

[Granulomatous mastitis and corynebacteria infection. Two case reports].

Diagnosis of granulomatous mastitis must be based on a multidisciplinary approach. First, it's necessary to eliminate carcinomatous mastitis. Usually, the diagnosis is unknown except for tuberculous and sarcoidosis granulomatous mastitis. On observations in two cases of Corynebacterium granulomatous mastitis, we discussed the diagnosis and therapeutic approach. When there is a clinical suspicion of granulomatous mastitis, surgical biopsy with immediate histological analysis and bacteriological culture of mammary tissue should be performed. This multidisiplinary approach should reduce the number of idiopathic granulomatous mastitis observed. Antibiotic treatment is required after biopsy or surgical excision of granuloma.

Adult↗

Bacterial growth, inflammatory cytokine production, and neutrophil recruitment during coliform mastitis in cows within ten days after calving, compared with cows at midlactation.

OBJECTIVE: To define causes of increased susceptibility to coliform mastitis after parturition. ANIMALS: 12 healthy Holstein cows assigned to 2 groups. Group-1 cows (n = 6) had calved between 6 and 10 days earlier. Group-2 cows (n = 6) were in midlactation. PROCEDURE: Cows from each group were paired and challenge exposed with Escherichia coli in 1 mammary gland. Mastitis severity was determined by bacterial concentration in milk, pyrexia, and milk production. Measures of host defense were neutrophil chemotaxis, adhesion molecule expression, leukocyte recruitment, and cytokine production. RESULTS: After challenge exposure, group-1 cows had more rapid E coli growth, higher peak bacterial concentration, and higher fever. Leukocyte recruitment was poor in 1 group-1 cow that had peracute mastitis. In contrast, leukocyte recruitment in 5 other group-1 cows began sooner than that in group-2 cows. In these group-1 cows, prechallenge-exposure milk somatic cell counts (SCC) were significantly lower than those in group-2 cows. Prechallenge-exposure SCC were correlated to stimulated CD18 expression (R2 = 0.79), and both measures correlated inversely with bacterial growth rate (R2 = -0.75). Values for tumor necrosis factor alpha, interleukin 1, and interleukin 8 in group-1 cows after challenge exposure were greater than or equal to those in group-2 cows. CONCLUSIONS: Weak leukocyte recruitment to the mammary gland is associated with increased severity of coliform mastitis. Impaired production of cytokines measured is not a cause of increased susceptibility to coliform mastitis in early lactation. CLINICAL RELEVANCE: Low milk SCC after calving may increase susceptibility to severe coliform mastitis.

Animals↗

Factors associated with clinical mastitis incidence in French dairy herds during late gestation and early lactation.

A prospective epidemiological survey was conducted in dairy herds in Brittany (France), concerning 139 herd-years. The data were divided into ten 14 herd-year groups (deciles) and three of these were compared using discrimination by barycentric analysis to study herd late gestation and early lactation variables associated with the annual incidence of herd clinical mastitis in the first 60 days of gestation (CMAI). The first decile included herd-years with low CMAI (o to 4.6%), the second decile, herd-years with medium CMAI (11.6 to 14.3%) and the last decile, herd-years with high CMAI (26.3 to 45.5%). Herd data included diet components, milk yield and reproduction parameters, clinical diseases, body condition score, body dirtiness score and circulating biochemical and hematological markers. The high CMAI group had the following characteristics: 1) lower percentages of dried cows supplemented with vitamins 'ADE'; 2) higher levels of plasma ceruloplasmin and higher gamma glutamyl transferase activities (GGT) in the late gestation period; 3) higher percentages of winter calvings (December, January, February). Clinical mastitis risk could be controlled by supplementations with vitamins A, D and E in the late gestation period, because of the potential relationship between oxidative stress and mastitis. Higher GGT activities would be associated with Fasciolasis via common climatic risk factors (rainfall, humidity) for both mastitis and liver flukes. Winter calving and clinical mastitis would be associated with unfavourable hygiene conditions and stress at calving related to high animal density and bad weather conditions. Ceruloplasmin could be a specific predictor for mastitis risk through nutritional, immune and genetic interrelated factors.

Animal Feed↗

In vivo studies on lysosubtilin. 3. Efficacy for treatment of mastitis and superficial lesions of the udder and teats in cows.

Lysosubtilin is a broad-spectrum preparation of lytic enzymes from Bacillus subtilis designed for veterinary medicine. This study demonstrates its efficacy for the treatment of reproductive system diseases (mastitis, superficial lesions of the udder and teats) in cows. Prior to determination of optimal therapeutic doses, samples taken from the milk and udder skin of sick animals were examined microbiologically. The examinations revealed a high incidence of polymicrobial infections (26.9 and 84.9% for mastitis and superficial udder lesions, respectively) caused by various mixtures of bacteria (both Gram-positive and Gram-negative) and fungi/yeasts. Dose determination studies involved 115 cows with clinical signs of mastitis. The optimal dose for mastitis treatment was found to be 3.5 x 10(6) U lysosubtilin dissolved in 100 mL of distilled water, which was then administered into the mammary gland via the teat canal once daily until recovery. Such a dose yielded statistically significant decreases (P < 0.05) both in the length of time before clinical recovery (2 d versus 4 and 4.5 d with either of the two antibiotic-based traditional drugs) and in the percentage of animals who suffered relapses within a 2-month period following treatment (5% versus 60%, with one of the two drugs). A field experiment involving 106 cows was designed to compare the efficacy of 1% lysosubtilin water-glycerin solution (1:9 v/v) and other traditional medications for the topical treatment of superficial lesions of the udder and teats as well as its potential for mastitis prevention. All drugs used yielded a 100% cure rate, but lysosubtilin application made it possible to achieve a statistically significant decrease (P < 0.05) in the duration of the recovery period (2.5 d versus 4.5 to 5.5 d) when compared with any of the four other drugs tested. Its efficacy for mastitis prevention was at least 3.4 times higher than the efficacy of the other medications used (statistically significant, P < 0.05, with regards to two of the four drugs) as well. We therefore conclude that lytic enzyme preparations are prospective antimicrobial drugs and when used to combat animal diseases they may serve as a possible alternative to common antibiotics.

Animals↗

Association between milk somatic cell counts up to 400,000 cells/ml and clinical mastitis in French Holstein cows.

The relationship between somatic cell counts (SCCs) up to 400,000 cells/ml in individual cows and clinical mastitis was studied by collecting monthly records for a year from 101 Holstein herds in the west of France. Monthly records obtained after any case of clinical mastitis occurring within the lactation were excluded. The resulting dataset consisted of 29,700 records from 4677 cows. The data were analysed by the logistic regression method. Herd, lactation number, calendar month, milk production, stage of lactation on the day of test, and SCC on previous test days were assumed to affect the likelihood of clinical mastitis. There was no significant relationship between SCC and the subsequent occurrence of clinical mastitis for an SCC up to 100,000 cells/ml, but the risk of clinical mastitis increased as the SCC increased up to 400,000 cells/ml. These results suggest that in individual cows, a low SCC recorded after five days in milk does not lead to an increased risk of clinical mastitis.

Animals↗

Efficacy of lincosaminide antibiotics in the treatment of experimental staphylococcal mastitis in lactating mice.

Staphylococcus aureus is a frequent cause of bovine mastitis worldwide. A model that may predict the efficacy of antimicrobial agents in the treatment of bovine mastitis induced by Staph. aureus was developed in lactating mice. Infection was established by the inoculation of lactating CF1 mice with Staph. aureus into the mammary gland via the teat duct. At the dose of bacteria used, 85-90% of the inoculated, untreated animals developed a nonlethal, acute mastitis within 48 h. Antibiotic treatment was administered subcutaneously or by the intramammary route. Lincosaminide antibiotics including lincomycin, clindamycin, and pirlimycin were evaluated in this system. Other compounds which have been used in therapy of bovine mastitis including novobiocin, penicillin G, ampicillin, cloxacillin and rifamycin-SV were used as reference antibiotics. Pirlimycin was the most effective of the antibiotics tested in this standardized system. Depending upon the route of administration, this novel lincosaminide was 15 to 95-fold more effective than clindamycin, three- to six-fold better than lincomycin, two- to ten-fold more effective than novobiocin, 13- to 17-times more effective than cloxacillin and 8- to 22-times better than rifamycin-SV on a weight-dose comparison. Penicillin G and ampicillin were the least effective drugs tested against mastitis induced by the beta-lactamase producing strain of Staph. aureus used in these assays. Pharmacokinetic experiments suggested that the greater effectiveness of pirlimycin compared to clindamycin and lincomycin was due to increased affinity for and prolonged retention in the mammary gland.

Animals↗

[Therapeutic aspects of coli mastitis in ruminants].

Cows with coliform mastitis showed, in addition to fever, tachycardia and ruminal stasis and a concatenation of nonspecific responses, such as neutrophylic leukopenia followed by leukocytosis, lymphopenia, hypocalcaemia, hypoferraemia, hypozincaemia, and hypercupremia, and changes in the concentration of certain serum proteins. Similar responses occurred in cows and goats when mastitis was induced by an E. coli endotoxin or following the i/v injection of such endotoxin. Research suggested that in cows with clinical mastitis the symptoms of a generalized disease were predominantly the result of the release of phagocyte endogenous proteins at the site of inflammation in the mammary gland. Another inflammatory protein was the leukocytic endothelial mediator which changed the plasma concentrations of trace elements. Local treatment with the rather toxic antibiotic, polymyxin B, blocked the effect of the endotoxin administered via the udder on plasma Zn and Fe values. Therefore, local treatment with this drug seemed to be indicated with cows having E. coli mastitis. Based on pharmacokinetic behaviour parenteral treatment of such cows with trimethoprim or chloramphenicol appeared to be interest. Furthermore fluboprofen, a nonsteroid antiinflammatory agent was shown to possess a beneficial effect in cows with experimental E. coli mastitis.

Animals↗

Differential protein composition of bovine whey: a comparison of whey from healthy animals and from those with clinical mastitis.

During clinical mastitis in dairy cows, the quantity of milk produced decreases and the composition of the milk is altered. As the severity of inflammation associated with the disease increases, the chemical composition of milk approaches that of blood as a consequence of increased permeability of the blood mammary barrier, or de novo intramammary synthesis, as has been suggested for mammary associated serum amyloid A3. A better understanding of these events may provide new approaches for the diagnosis and treatment of mastitis. The objective of this study was to document the changes in the protein composition of milk during clinical mastitis using a proteomic approach, with the objective of identifying new diagnostic markers of mastitis. Whey from dairy cows with clinical mastitis was compared to whey from healthy animals by two-dimensional gel electrophoresis (2-DE) with colloidal Coomassie staining and matrix-assisted desorption/ionization mass spectrometry. Increases in the concentrations of proteins of blood serum origin, including serotransferrin and albumin, were identified in mastitic whey compared to normal whey, while concentrations of the major whey proteins alpha-lactalbumin and beta-lactoglobulin were reduced in mastitic whey. Mass spectrometry subsequently confirmed the location of albumin, alpha-lactalbumin and beta-lactoglobulin on the 2-DE gels at M(r)/pI of 69 294/5.8, 14 200/4.5 and 19 883/4.9 respectively.

Animals↗

Human milk anti-inflammatory component contents during acute mastitis.

Mastitis is a common complication of human lactation. We examined milk specimens from eight women with clinical mastitis to determine their content of anti-inflammatory components. Antioxidant activity (spontaneous cytochrome c reducing activity), selected pro-inflammatory cytokines (IL-6, IL-1beta), selected endogenous cytokine control molecules (sIL-6R, sIL-1RII, and sTNFRI), lactoferrin, Na(+):K(+) ratios, and milk bioactivities that cause shedding of sIL-1RII from human polymorphonuclear leukocytes (PMN), suppress PMN aggregation, and suppress PMN adherence responses were not increased compared to normal milks. Neither the bioactivities that deplete PMN intracellular Ca(2+) stores nor those that block Ca(2+) influx into fMLP-stimulated PMN were significantly increased in mastitis milks. In contrast, levels of TNFalpha, sTNFRII, and IL-1RA and bioactivities that cause shedding of sTNFRI from human PMN were significantly increased compared to normal milks. Mastitis milk has the same anti-inflammatory components and characteristics of normal milk, with elevations in selected components/activities that may help protect the nursing infant from developing clinical illness due to feeding on mastitis milk.

Adult↗

Subclinical mastitis as a risk factor for mother-infant HIV transmission.

Subclinical mastitis, as diagnosed by an elevated sodium/potassium ratio in milk accompanied by an increased milk concentration of the inflammatory cytokine, interleukin-8 (IL8), was found to be common among breast feeding women in Bangladesh and Tanzania. Subclinical mastitis results in leakage of plasma constituents into milk, active recruitment of leukocytes into milk, and possible infant gut damage from inflammatory cytokines. Therefore, we wished to investigate whether subclinical mastitis was related to known risk factors for postnatal mother-to-child HIV transmission, that is, high milk viral load or increased infant gut permeability. HIV-infected South African women were recruited at the antenatal clinic of McCord's Hospital, Durban. Risks and benefits of different feeding strategies were explained to them and, if they chose to breast feed, they were encouraged to do so exclusively. Women and infants returned to the clinic at 1, 6 and 14 weeks postpartum for an interview about infant health and current feeding pattern, a lactulose/mannitol test of infant gut permeability, and milk sample collection from each breast separately for analysis of Na/K ratio, IL8 concentration and viral load in the cell-free aqueous phase. Only preliminary cross-sectional analyses from an incomplete database are available at this point. Moderately (0.6-1.0) or greatly (>1.0) raised Na/K ratio was common and was often unilateral, although as a group right and left breasts did not differ. Considering both breasts together, normal, moderately raised or greatly raised Na/K was found, respectively, in 51%, 28%, 21% of milk samples at 1 week (n=190); 69%, 20%, 11% at 6 weeks (n=167); and 72%, 16%, 12% at 14 weeks (n=122). IL8 concentration significantly correlated with both Na/K and viral load at all times. Na/K correlated with viral load at 1 and 14, but not 6 weeks. At 1 and 14 weeks, geometric mean viral loads in samples with Na/K > 1.0 were approximately 4 times those in samples with Na/K < 0.6. At 1 week but not later times, exclusive breast feeding was associated with lower milk viral load than was mixed feeding. Gut permeability was unrelated to milk Na/K ratio or IL8 concentration and was not significantly increased by inclusion of other foods than breast milk in the infant's diet. The results suggest that subclinical mastitis among HIV-infected women may increase the risk of vertical transmission through breast feeding by increasing milk viral load. The importance of various causes of subclinical mastitis, which likely differ at 1 week from at later times and may include local infection or sterile inflammation, systemic infection, micronutrient deficiencies, or poor lactation practices, needs to be further clarified so that appropriate interventions can be implemented.

Africa South of the Sahara↗

Vaccines against bovine mastitis due to Streptococcus uberis current status and future prospects.

The prevalence of bovine mastitis in the UK has been reduced over the past twenty five years due to the implementation of a five-point control plan aimed at reducing exposure, duration and transmission of intramammary infections by bacteria. This has markedly reduced the incidence of bovine mastitis caused by bacteria which show a contagious route of transmission but has had little effect on the incidence of mastitis due to bacteria which infect the gland from an environmental reservoir. Streptococcus uberis is one such bacterium which is responsible for a significant proportion of clinical mastitis worldwide. The inadequacies of the current methods of mastitis control have led to the search for additional measures to prevent intramammary infection by this bacterium. A live vaccine in combination with an intramammary administration of a soluble cell surface extract was shown to induce protection of the mammary gland from experimental challenge with S. uberis. Protection was strain specific, but was achieved in the absence of opsonic activity and without a large influx of neutrophils. One hypothesis is that protection was achieved by reducing the rate of bacterial growth in vivo. This view has led to the identification and exploitation of a novel plasminogen activator as a vaccine antigen. Vaccines containing this antigen conferred cross strain protection.

Animals↗

[Clinical symptoms and aspiration biopsy cytology of chronic mastitis (author's transl)].

The clinical aspects of chronic mastitis and the author's results achieved by means of aspiration biopsy cytology are dealt with from the oncological point of view. It is stated that chronic mastitis occurs more rarely in these days than a few years ago. In the course of 1000 breast examinations made by means of aspiration biopsy cytology in 1967--1979, there were 17 cases of chronic, nonspecific mastitis, 1 tuberculous mastitis, 2 plasmocytic mastitis, and 1 case in which the simultaneous occurrence of tuberculosis and carcinoma were diagnosed with the help of this method. In the above diseases the accuracy of aspiration cytology is high. The procedure is fast, accurate, and can be performed on outpatients, too. Its application is recommended in all places where there are adequate conditions.

Biopsy, Needle↗

Quantitative trait loci affecting clinical mastitis and somatic cell count in dairy cattle.

Norway has a field recording system for dairy cattle that includes recording of all veterinary treatments on an individual animal basis from 1978 onwards. Application of these data in a genome search for quantitative trait loci (QTL) verified genome-wise significant QTL affecting clinical mastitis on Chromosome (Chr) 6. Additional putative QTL for clinical mastitis were localized to Chrs. 3, 4, 14, and 27. The comprehensive field recording system includes information on somatic cell count as well. This trait is often used in selection against mastitis when direct information on clinical mastitis is not available. The absence of common QTL positions for the two traits in our study indicates that the use of somatic cell count data in QTL studies aimed for reducing the incidence of mastitis should be carefully evaluated.

Animals↗

Classification of coagulase-negative staphylococci isolated from bovine clinical and subclinical mastitis.

One hundred and forty eight strains of coagulase-negative staphylococci (CNS) from bovine clinical and subclinical mastitis were classified by conventional biochemical testing. Staphylococcus simulans was the most frequently isolated species. The distribution of CNS species in the two groups was similar regardless of whether the cow suffered from clinical or subclinical mastitis. There was no significant difference between the grades of severity of the clinical mastitis associated with the various CNS. The small difference in pathogenicity observed between species in this study, and the similarity of distribution in the various species of clinical and subclinical mastitis could indicate that the species per se is of minor importance in the development of mastitis.

Animals↗